(a and b) Our immunoprecipitation attempts were not able to detect a physical interaction between SYT11 and ATP13A2 by western blotting and only retrieved two ATP13A2 peptides by mass spectrometry analysis of SYT11-co-immunoprecipitated proteins. GFP-tagged SYT11 overexpressing HeLa cells were immunoprecipitated using antibodies against GFP or ATP13A2 (a). Immunoprecipitates and respective whole cell lysates were blotted against GFP and ATP13A2. (b)Table summarizing peptide counts of ATP13A2 that co-immunoprecipitate with GFP-SYT11. Lysates of HeLa cells transfected with GFP-tagged SYT11 and V5-tagged ATP13A2 were used to GFP-immunoprecipitation followed by mass spectrometry analysis of co-immunoprecipitated proteins. (c) Western blot against ATP13A2 and actin confirming the knockdown efficiency of the siRNAs against ATP13A2 after 96 hours of transfection. The quantification represents the mean ± S.D. of three independent experiments. (d) Human neuroblastoma SH-SY5Y cells transfected with Control, SYT11 siRNA or ATP13A2 siRNA were used to measure the mRNA levels of SYT11 and GAPDH by real-time PCR. The graph represents the mean ± S.D. of one experiment with triplicates each condition. *** p < 0.001 (two-tailed unpaired Student's t-test) . (e) Western blot against ATP13A2 and actin confirming the knockdown efficiency of the lentiviral shRNAs against ATP13A2 in mouse primary neuron cultures after 5 days of transduction. The quantification represents the mean ± S.D. of three independent experiments. (f) Western blot against V5 and actin confirming the overexpression efficiencies of V5-tagged ATP13A2 WT, ATP13A2 delC or ATP13A2 i16 constructs after 24 hours of transfection. (g) HeLa cells transfected with Control, SYT11 siRNA or ATP13A2 siRNA were used to determine cellular apoptosis by flow cytometry using the AnnexinV-FITC/PI assay. Staurosporine (5 µg/ml for 4 hours) was used as a positive control. Phospho-p70S6K p70S6K Actin KD Phospho-p70S6K p70S6K Actin OE Phospho-p70S6K p70S6K Actin
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